Form 4 for TENX TENAX THERAPEUTICS, INC.
Accepted 2025-11-19 00:00:00 ET · period of report 2025-11-17 · accession 0001492647-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-19 | 2025-11-17+ | TENX | Almenoff June Sherie | Dir | P - Purchase | $7.50 | +1,993 | 1,993 | New | +$15.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-17 | P | A | 93 | $7.15 | 93 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-18 | P | A | 1,900 | $7.52 | 1,993 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $7.45 to $7.70. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |